Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Lyckegard Group AB | F55 | Nov 13, 2024 | 0.09 | +3.01 |
LYCOPODIUM LTD. | LW1 | Nov 13, 2024 | 6.40 | 0.00 |
LYCOS ENERGY INC. NEW | G4P0 | Nov 13, 2024 | 1.78 | +1.14 |
Lyft, Inc. - Class A | LY0 | Nov 13, 2024 | 17.02 | +0.29 |
Lynas Rare Earths Limited | LYI | Nov 13, 2024 | 4.62 | -3.75 |
Lynas Rare Earths Limited American Depositary Receipts - Spo | LYIC | Nov 13, 2024 | 4.70 | +2.62 |
LyondellBasell Industries NV Ordinary Shares Class A (Nether | DLY | Nov 13, 2024 | 78.32 | -1.09 |
Lytix Biopharma | 6BG | Nov 13, 2024 | 0.54 | +2.29 |
L`Oreal | LORA | Nov 13, 2024 | 66.00 | -2.94 |
M Vest Water | 7YA | Nov 13, 2024 | 0.69 | -2.11 |
M&C Saatchi | IZH | Nov 13, 2024 | 2.40 | 0.00 |
M&G | 7MP | Nov 13, 2024 | 2.35 | -1.18 |
M&T Bank Corporation | MTZ | Nov 13, 2024 | 199.30 | -1.73 |
M.P. Evans Group Plc | NYP | Nov 13, 2024 | 11.20 | +1.82 |
M/I Homes, Inc. | 4MI | Nov 13, 2024 | 145.40 | -4.09 |
M1 Kliniken AG | M12 | Nov 13, 2024 | 16.15 | -0.62 |
M3, Inc. | 4YC | Nov 13, 2024 | 8.05 | -1.23 |
MAANSHAN IRON | YM9A | Nov 13, 2024 | 0.14 | -0.72 |
Maat Pharma S.A. | 4RD | Nov 13, 2024 | 7.42 | +0.27 |
Mabion S.A. | 272 | Nov 13, 2024 | 2.64 | -3.83 |
Mabuchi Motor Co. Ltd. | V94 | Nov 13, 2024 | 13.40 | -0.74 |
Macarthur Minerals Ltd | MMLA | Nov 13, 2024 | 0.03 | +7.27 |
Macerich Company (The) | M6G | Nov 13, 2024 | 17.89 | -3.51 |
MacFarlane Group plc | 5K6 | Nov 13, 2024 | 1.27 | +0.79 |
Mack-Cali Realty Corporation | WY4 | Nov 13, 2024 | 17.60 | +2.92 |
MACOM Technology Solutions Holdings, Inc. | 1MA | Nov 13, 2024 | 122.00 | -1.61 |
MACQUARIE GROUP ADR 1 | 4M42 | Nov 13, 2024 | 135.00 | -1.46 |
Macquarie Group Ltd Ordinary shares (Australia) | 4M4 | Nov 13, 2024 | 138.18 | -2.30 |
MacroGenics, Inc. | M55 | Nov 13, 2024 | 3.73 | -6.65 |
Macromill, Inc. | MA5 | Nov 13, 2024 | 4.68 | -2.09 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.